Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release May 10 2023

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

Zydus Lifesciences Limited has issued a press release regarding the receipt of an Establishment Inspection Report from the USFDA for its manufacturing facility in Moraiya, Ahmedabad. The inspection, which focused on transdermal patch products, concluded with no observations. This disclosure is made in accordance with regulatory requirements to inform investors and exchange members.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated May 10, 2023, titled "Zydus receives EIR for the Pre-Approval Inspection (PAI) at the manufacturing facility in Moraiya, Ahmedabad".

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases